Shoulder Innovations, Inc. $SI Shares Sold by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC trimmed its stake in shares of Shoulder Innovations, Inc. (NYSE:SIFree Report) by 24.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 289,850 shares of the company’s stock after selling 92,517 shares during the quarter. TimesSquare Capital Management LLC owned about 1.41% of Shoulder Innovations worth $4,145,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Deerfield Management Company L.P. bought a new position in Shoulder Innovations during the 3rd quarter valued at $6,056,000. Alyeska Investment Group L.P. bought a new position in Shoulder Innovations during the 3rd quarter valued at $5,667,000. Federated Hermes Inc. bought a new position in Shoulder Innovations during the 3rd quarter valued at $2,510,000. Vanguard Group Inc. bought a new position in Shoulder Innovations during the 3rd quarter valued at $1,836,000. Finally, Citadel Advisors LLC bought a new position in Shoulder Innovations during the 3rd quarter valued at $628,000.

Analyst Ratings Changes

SI has been the subject of a number of research reports. BTIG Research increased their price target on Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, March 11th. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $21.00.

Check Out Our Latest Report on Shoulder Innovations

Shoulder Innovations Stock Performance

Shares of NYSE SI opened at $14.94 on Wednesday. The stock has a fifty day moving average price of $14.20 and a two-hundred day moving average price of $14.07. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. The firm has a market cap of $309.92 million and a P/E ratio of -0.09. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $17.94.

Shoulder Innovations (NYSE:SIGet Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.03. The business had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. Research analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.

Insider Buying and Selling at Shoulder Innovations

In related news, CFO Jeffrey S. Points acquired 2,000 shares of Shoulder Innovations stock in a transaction dated Friday, March 13th. The stock was acquired at an average cost of $15.00 per share, with a total value of $30,000.00. Following the purchase, the chief financial officer directly owned 70,785 shares in the company, valued at $1,061,775. The trade was a 2.91% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Robert Joseph Ball acquired 2,200 shares of Shoulder Innovations stock in a transaction dated Friday, March 13th. The shares were bought at an average cost of $15.18 per share, with a total value of $33,396.00. Following the completion of the purchase, the chief executive officer owned 278,866 shares in the company, valued at approximately $4,233,185.88. This represents a 0.80% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have bought 5,200 shares of company stock valued at $78,236. Corporate insiders own 29.00% of the company’s stock.

About Shoulder Innovations

(Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Further Reading

Want to see what other hedge funds are holding SI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shoulder Innovations, Inc. (NYSE:SIFree Report).

Institutional Ownership by Quarter for Shoulder Innovations (NYSE:SI)

Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.